Chunsheng Dong
Jiangsu Key Laboratory Of Infection And Immunity, MOE Key Laboratory Of Geriatric Diseases And Immunology
Suzhou, China
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
TGF-β in tumor development and progression: mechanisms and therapeutics.
Journal: Molecular biomedicine
Published: May 08, 2025
Novel signals for naive lymphocyte recruitment under inflammation.
Journal: Molecular biomedicine
Published: January 14, 2025
The Deubiquitinase OTUD1 Influences HIV-1 Release by Regulating the Host Restriction Factor BST-2.
Journal: Viruses
Published: December 04, 2024
Tumor Microenvironment: Obstacles and Opportunities for T Cell-Based Tumor Immunotherapies.
Journal: Molecular cancer research : MCR
Published: August 09, 2024
A novel vesicular stomatitis virus armed with IL-2 mimic for oncolytic therapy.
Journal: Virologica Sinica
Published: February 16, 2024
Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein.
Journal: Antiviral research
Published: November 15, 2021
Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy.
Journal: Translational oncology
Published: September 01, 2021
A single dose of recombinant VSV-RABVG vaccine provides full protection against RABV challenge.
Journal: Virologica Sinica
Published: July 20, 2021
Mycobacterium tuberculosis Rv1096, facilitates mycobacterial survival by modulating the NF-κB/MAPK pathway as peptidoglycan N-deacetylase.
Journal: Molecular immunology
Published: December 17, 2019
USP39 Serves as a Deubiquitinase to Stabilize STAT1 and Sustains Type I IFN-Induced Antiviral Immunity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 21, 2019
RELL1 inhibits autophagy pathway and regulates Mycobacterium tuberculosis survival in macrophages.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: September 28, 2019
Last Updated: 09/26/2026